Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: A meta-analysis

HIV Medicine

Volumn 7, Issue 3, 2006, Pages 173-180

  Zhang, W ^a   Chaloner, Kathryn ^a   Tillmann, H L ^d   Williams, C F ^e   Stapleton, J T ^b,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Bayesian meta analysis; GB virus C; Hepatitis G virus; HIV; Survival

Indexed keywords

VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BAYES THEOREM; CAUSE OF DEATH; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; HEPATITIS G; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDLINE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PUBLICATION; SEROCONVERSION; SUPERINFECTION; SURVIVAL; SYSTEMATIC REVIEW; VIREMIA;

ADULT; BAYES THEOREM; FEMALE; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; TIME FACTORS; VIRAL LOAD; VIREMIA;

EID: 33644772501     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2006.00366.x     Document Type: Article

References (39)

1. Linnen J, Wages J, Zhang-Keck Z-Y et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996; 271: 505-508.
2. Simons JN, Leary TP, Dawson GJ et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564-569.
3. Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997; 37: 569-572.
4. Stapleton JT. GB virus type C/hepatitis G virus. Semin Liver Dis 2003; 23: 137-148.
5. Stapleton JT, Williams CF, Xiang J. GB virus C: A beneficial infection? J Clin Microbiol 2004; 42: 3915-3919.
6. Rambusch EG, Wedemeyer H, Tillmann HL, Heringlake S, Manns MP. Significance of coinfection with hepatitis G virus for chronic hepatitis C - a review of the literature. Z Gastroenterol 1998; 36: 41-53.
7. Tillmann HL, Heringlake S, Trautwein C et al. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 1998; 28: 379-384.
8. Xiang J, Wünschmann S, Schmidt WN, Shao J, Stapleton JT. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 2000; 74: 9125-9133
9. Thomas DL, Vlahov D, Alter HJ, Marshall R, Astemborski J, Nelson KE. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998; 177: 539-542.
10. Klinzman D, Katz L, George SL, Chang Q, Xiang J, Zdunek D, Hess G, Schmidt WN, LaBrecque DR, Stapleton JT (2004). GB virus C/hepatitis G virus: Does clearance of viremia differ based on mode of transmission? Jilbery AR, Gragacic EVL, Vickery K, Burrl CJ, Cossart EE (eds.), 11th International Symposium on Viral Hepatitis and Liver Disease, pp. 488-490, Australian Center for Hepatitis Virology, Melbourne.
11. Williams CF, Klinzman D, Yamashita TE et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350: 981-990.
12. Heringlake S, Ockenga J, Tillmann HL et al. GB virus C/hepatitis G virus infection: A favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998; 177: 1723-1726.
13. Lefrère JJ, Roudot-Thoraval F, Morand-Joubert L et al. Carriage of GB virus C/hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 1999; 179: 783-789.
14. Xiang J, Wünschmann S, Diekema DJ et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001; 345: 707-714.
15. Tillmann HL, Heiken H, Knapik-Botor A et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001; 345: 715-724.
16. Xiang J, George SL, Wünschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1α, MIP-1β, and SDF-1. Lancet 2004; 363: 2040-2046.
17. + T-lymphocytes derived soluble factors independent of SDF-1. AIDS, 2005; 19: 1267-1272.
18. Nunnari G, Nigro L, Palermo F et al. Slower progress of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003; 139: 26-31.
19. Nattermann J, Nischalke HD, Kupfer B et al. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003; 17: 1457-1462.
20. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 209-213.
21. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002; 16: 2482-2485.
22. Björkman P, Flamholc L, Nauclér A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004; 18: 877-886.
23. Van der Bij AK, Kloosterboer N, Prins M et al. GB virus C coinfection and HIV-1 disease progression: The Amsterdam Cohort Study. J Infect Dis 2005; 191: 678-685.
24. Mosier DE, Chisari FV. GB virus C and mortality from HIV infection. N Engl J Med 2002; 346: 377-379.
25. Stapleton JT, Chaloner K. GB virus C and survival in HIV-positive people. AIDS 2004; 18: 1-12.
26. Normand ST. Tutorial in Biostatistics. Meta-analysis: Formulating, evaluating, combining, and reporting. Stat Med 1999; 18: 321-359.
27. Higgins JP, Spiegelhalter DJ. Being sceptical about meta-analyses: A Bayesian perspective on magnesium trials in myocardial infarction. Int J Epidemiol 2002; 31: 96-104.
28. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian Approaches to Clinical Trials and Health-Care Evaluation. Chichester, UK, Wiley, 2004: 267-299.
29. Tierney L. Markov chains for exploring posterior distributions (with discussion). Ann Statistics 1994; 22: 1701-1762.
30. R Development Core Team (2005). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, URL http://www.r-project.org.
31. Sabin CA, Devereux H, Kinson Z et al. Effect of coinfection with hepatitis G virus on HIV disease progression in hemophilic men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 546-548.
32. Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Ann Intern Med 2000; 132: 959-963.
33. Brumme ZL, Chan KJ, Dong WW et al. No association between GB virus-C viremia and virological or immunological failure after starting initial antiretroviral therapy. AIDS 2002; 16: 1929-1933.
34. Brust D, Jagannatha S, Herpin B et al. Hepatitis G virus (HGV) infection does not prolong survival of patients with early-stage HIV disease: importance of baseline HIV viral load as a predictor of mortality. XIV International AIDS Conference. Barcelona, Spain, July 2002 [Abstract WeOr1378].
35. Kaye S, Howard M, Alabi A, Hansmann A, Whittle H, Schim van der Loeff M. No observed effect of GB virus C coinfection on disease progression in a cohort of African women infected with HIV-1 or HIV-2. Clin Infect Dis 2005; 40: 876-878.
36. Geskus RB. On the inclusion of prevalent cases in HIV/AIDS natural history studies through a marker-based estimate of time since seroconversion. Stat Med 2000; 19: 1753-1769.
37. Stapleton JT, Chaloner K, Williams CF. GB virus C infection and survival in the Amsterdam Cohort Study. J Infect Dis 2005; 191: 2157-2158.
38. Xiang J, George SL, Wünschmann S et al. GBV-C infection inhibits CCR5 and CXCR4 HIV strains, and alters chemokine and cytokine gene expression in PBMC cultures. 10th Conference on Retroviruses and Opportunistic Infections. Boston, MA, USA, February 2003 [Oral Presentation].
39. Bisson G, Strom B, Gross R et al. GB virus C viremia in HIV-uninfected adults does not decrease the risk of HIV infection or lower the HIV viral load set-point after HIV acquisition. AIDS 2005; 19: 1910-1912.